|1.||Giacometti, Andrea: 8 articles (04/2008 - 11/2002)|
|2.||Scalise, Giorgio: 8 articles (04/2008 - 11/2002)|
|3.||Cirioni, Oscar: 8 articles (04/2008 - 11/2002)|
|4.||Kamysz, Wojciech: 7 articles (04/2008 - 11/2002)|
|5.||Saba, Vittorio: 6 articles (04/2008 - 11/2002)|
|6.||Ghiselli, Roberto: 6 articles (04/2008 - 11/2002)|
|7.||Orlando, Fiorenza: 6 articles (04/2008 - 11/2002)|
|8.||Silvestri, Carmela: 5 articles (04/2008 - 08/2004)|
|9.||Mocchegiani, Federico: 5 articles (07/2006 - 11/2002)|
|10.||Lukasiak, Jerzy: 3 articles (01/2006 - 11/2002)|
11/01/2007 - "The plant-optimized nucleotide sequences encoding MsrA2 and temporin A were transcriptionally fused to the inducible win3.12T poplar promoter, which had strong systemic activity in response to fungal infection, and introduced into tobacco (Nicotiana tabacum L. "
08/12/2003 - "The combinations of temporin A and RIP exerted the strongest antistaphylococcal efficacies, eliminating infection by 100%. "
11/01/2002 - "The purpose of this study was to investigate the efficacy of temporin A as a prophylactic agent in a rat model of vascular graft infection from methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis. "
11/01/2002 - "Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection."
08/01/2004 - "The efficacy of linezolid and temporin A in the prevention of prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides was investigated in a subcutaneous rat pouch model. "
11/01/2005 - "This study shows that temporin A can reduce the stimulatory effects of bacterial cell components and suggests that it may be beneficial in the treatment of severe staphylococcal sepsis."
11/01/2005 - "Also, mouse models of staphylococcal sepsis were used to evaluate the efficacy of temporin A alone and in combination with imipenem. "
11/01/2005 - "Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis."
|3.||Wounds and Injuries (Trauma)
04/01/2008 - "In conclusion our results demonstrated that temporin A is effective in the management of infected wounds, by a significant bacterial growth inhibition and acceleration of wound repair process."
04/01/2008 - "Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model."
04/01/2008 - "We investigated the effect of topical temporin A in the management of methicillin-resistant strain of Staphylococcus aureus (MRSA)-infected experimental surgical wounds in mice. "
|5.||Surgical Wound Infection
11/01/2005 - "The in vitro activities of three amphibian peptides magainin II amide, citropin 1.1 and temporin A alone and in combination with eight clinically used antimicrobial agents (imipenem, ceftazidime, clarithromycin, vancomycin, amikacin, polymyxin E, ciprofloxacin and linezolid) were investigated against several multidrug-resistant Pseudomonas aeruginosa and Staphylococcus aureus strains isolated from surgical wound infections. "
|5.||RNAIII inhibiting peptide
|6.||Anti-Bacterial Agents (Antibiotics)
|7.||Uperoleia mjobergii uperin 3.6 peptide
|8.||antimicrobial peptide IB-367 (iseganan)